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Introduction
Professional medical groups commonly
issue clinical practice guidelines. Such
guidelines are traditionally the result of
consensus conferences or expert panels
and represent attempts to synthesize—
from the best available evidence and
expertise—practical guidance on the best
possible care. Beyond issuing a guideline,
many organizations have felt the need to
provide a grading of each guideline’s
quality, thereby conveying to the reader
a sense of the confidence that might be
placed in it. This article addresses only the
grading of guidelines, not their use or
development.
The idea that evidence in the medical
literature should be graded was initially
proposed in publications from McMaster
University [1–3], with the idea of catego-
rizing individual studies into grades of
reliability ranging from randomized con-
trolled trials (most reliable) to case reports
with expert opinion (least reliable). Grad-
ing of guidelines followed, but this has
been besieged with problems. To give one
example, a guideline by Ferraris and
colleagues gave the use of aprotonin
during high-risk cardiac surgery a ‘‘high-
grade’’ recommendation [4], but this
intervention was subsequently shown to
increase mortality [5].
The pursuit of better approaches to
grading guidelines has resulted in GRADE
(Grades of Recommendation Assessment,
Development and Evaluation), introduced
in 2004 [6]. GRADE has been adopted
‘‘unchanged or with only minor modifica-
tions’’ by national and international pro-
fessional medical societies, health-related
branches of government, health care
regulatory bodies, and UpToDate, an
on-line medical resource that is accessed
by trainees and physicians in most US
academic medical centers (Box 1) [7,8].
The developers of the GRADE system
emphasized consistency in the rating of
guidelines, as well as a wish to incorporate,
and distinguish between, the ‘‘strength’’ of
each guideline and the ‘‘quality’’ of the
underlying studies (i.e., evidence) upon
which it is based. Yet there is a central
paradox: while GRADE has evolved
through the evidence-based medicine
movement, there is no evidence that
GRADE itself is reliable.
Are Different Guidelines Externally
Consistent?
GRADE is one of several different
systems for grading clinical evidence and
creating clinical practice guidelines based
on this underlying evidence. How do these
systems compare with each other?
Atkins and colleagues, from the GRADE
Working Group, compared six different
systems (Box 2) [9]. Twelve assessors
independently evaluated each system on
the basis of 12 criteria to assess the
‘‘sensibility’’ (overall usefulness) of the differ-
ent approaches. There was poor agreement
between them. In the absence of a proven
gold standard, such disagreement signals
concern about the inherent validity of any of
these grading systems. Commenting on this
lack of agreement, the authors wrote that a
new system—GRADE—could overcome
the problems [9].
But the example of the Surviving Sepsis
Campaign (SSC), an important attempt to
produce guidelines to improve the care of
patients with sepsis or septic shock,
suggests that GRADE has not overcome
these problems (see Boxes 3 and 4) [10–
11]. The endorsement of the SSC by
many influential organizations under-
scores its importance [10–11]. Nonethe-
less, the SSC illustrates some of the
important difficulties with grading in
general and with the GRADE system in
particular. There are three reasons why I
focus here on the SSC. First, sepsis
encompasses all medical and surgical
specialties, accounts for over 500,000
emergency visits per year in North Amer-
ica alone [12], and when accompanied by
shock has a mortality of over 50% [13].
Second, the SSC may have significant
impact: some believe that incorporating
the SSC guidelines could save up to
100,000 lives in an 18-mo interval [14].
Third, the SSC is the best known source of
advice on managing sepsis and all of its
recommendations carry a grading. Finally,
because the SSC published two documents
4 y apart (in 2004 and 2008 [10–11]), it
presents a unique opportunity to compare
interval changes. I focus only on grading
(Boxes 3 and 4), not on the controversies
surrounding the SSC [15], and I do not
express support for—or criticism of—any
of its recommendations.
Is GRADE Internally Consistent?
Inter-rater agreement of GRADE.
In 2005, the GRADE working group—all
experts who themselves developed the
GRADE system—published a pilot study
of thesystem [16]. The studyfound that the
kappa value (i.e., the inter-rater agreement
beyond chance) for 12 judgments about the
quality of evidence was very low (mean
k=0.27; k,0 for four judgments). The
authors stated that ‘‘with discussion’’ they
were able to considerably improve their
system, but provided no supportive data.
Furthermore, the presentation of GRADE
that had been published a year earlier in
2004 contains neither assessment of
reliability, agreement, nor proof of
usefulness [6].
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experts. Comparing expert opinion on
sepsis with the result of the GRADE
process further suggests that GRADE
lacks internal consistency.
First, glucose control in the critically ill
is a complex issue [17]. Recent clinical
data suggest no benefit to widespread
application of ‘‘tight’’ glucose control
(i.e., intensive insulin therapy) in most
intensive care unit (ICU) patients [18–21].
Brunkhorst and colleagues state that
intensive insulin therapy has ‘‘no measur-
able consistent benefit in critically ill
patients in a medical ICU regardless of
whether the patients have severe sepsis
and that such therapy increases the risk of
hypoglycemic episodes’’ [18]. Yet the
senior author of that report [18], Konrad
Reinhart, is a coauthor of the SSC
guidelines that gave a grade 1 ranking
(strong recommendation) for ‘‘moderate’’
glucose control and a grade 2 endorse-
ment (a suggestion) for ‘‘tight’’ glucose
control [11]. No evidence exists for
moderate glucose control in this context,
whereas the value of tight control was
supported by one single-centre random-
ized controlled trial (RCT) [22] and
opposed by four others [18,20–21,23].
Since the 2008 SSC forum [11], the
largest multicentre study, the NICE-Sugar
trial, reported that tight glucose control
increased ICU mortality by 2.6% (OR
1.14) [24].
Second, the SSC strongly recommends
(i.e., grade 1) specific resuscitation targets
(blood pressure, urine output, central venous
pressure, central venous oxygenation) [11],
on the basis of the protocol of a commonly
cited single-centre study [25]. In a different
forum, the SSC states: ‘‘It is impossible to
determine from the study which particular
facet of the protocol was beneficial for the
patients, so the protocol as a whole must be
recommended’’ [26]. But there is consider-
able debate about the usefulness of this
protocol—two ongoing studies are examin-
ing if the protocol is effective [27–28]. One
of these studies is led by Derek Angus, an
author of the SSC guidelines [11]. Thus, I
see an inconsistency in a grading system
where the most authoritative expert in the
SSC panel is investigating if the protocol is
useful versus the aggregate panel decision
concluding a strong recommendation that it
should be used [11].
Is GRADE Inherently Logical?
Strength of recommendation and
quality of evidence. GRADE provides
an expression of the strength of the
recommendation and also provides a
rating on the quality of the evidence upon
which the recommendation is based. In
terms of strength, GRADE considers
evidence to be ‘‘strong’’ or ‘‘weak.’’ The
GRADE group considers strength to reflect
‘‘the degree of confidence that the desirable
effects of adherence to a recommendation
outweigh the undesirable effects’’ [7]. This
component makes sense, but less so when
the strength of the recommendation is
dissociated from its foundation (i.e., the
quality of the evidence that underpins the
recommendation). The group emphasizes
the importance of making this dissociation:
‘‘Separating the judgments regarding the
quality of evidence from judgments about
the strength of recommendations is a
critical and defining feature of this new
grading system’’ [7]. One can envision
having ‘‘high-quality’’ knowledge that
points to a small effect (high quality, low
strength). The converse, low quality
knowledge that yields a high-strength
recommendation seems implausible, other
than perhaps the avoidance of substances
such as potent toxins.
Combining incommensurate ele-
ments. Another problem is the ‘‘leveling’’
processproposedtodeterminethequalityof
the evidence. GRADE ranks the quality of
evidence on the basis of the type of study,
‘‘quality’’ issues (e.g., blinding, follow-up,
sparseness of data), consistency, directness
(generalizability), and effect size. The
graders are instructed to raise or lower the
level of quality and trade off, for example,
the presence of sparse data against
demonstration of a dose-response effect
[6]; of course these are fundamentally
different and can therefore be neither
added nor subtracted.
GRADE Has Not Been Validated
The basis for the GRADE system is
articulated in several publications [6–
7,9,16,29–31], but none contains support-
ive data, proof, or logical argument for the
system. Rather, there is extensive refer-
ence to other papers written largely by the
same group but with no data (except a
very low kappa value for inter-observer
agreement) [16]. Thus, there is no litera-
ture-based proof of the validity of the
Box 1. Organizations That
Have Adopted the Grade
System
Agency for Healthcare Research and Quality
(USA)
Agenzia Sanitaria Regionale (Italy)
American College of Chest Physicians (USA)
American College of Physicians (USA)
American Thoracic Society (USA)
A ¨rztliches Zentrum fu ¨r Qualita ¨t in der Medizin
(Germany)
British Medical Journal (United Kingdom)
BMJ Clinical Evidence (United Kingdom)
COMPUS at The Canadian Agency for Drugs
and Technologies in Health (Canada)
The Cochrane Collaboration (International)
EMB Guidelines (Finland/International)
The Endocrine Society (USA)
European Respiratory Society (Europe)
European Society of Thoracic Surgeons
(International)
Evidence-based Nursing Su ¨dtirol (Italy)
German Center for Evidence-based Nursing
‘‘sapere aude’’ (Germany)
Infectious Diseases Society of America (USA)
Japanese Society for Temporomandibular
Joint (Japan)
Journal of Infection in Developing Countries
(International)
Kidney Disease: Improving Global Outcome
(International)
Ministry for Health and Long-Term Care,
Ontario (Canada)
National Board of Health and Welfare (Sweden)
National Institute for Health and Clinical
Excellence (United Kingdom)
Norwegian Knowledge Centre for the Health
Services (Norway)
Polish Institute for EBM (Poland)
Society for Critical Care Medicine (USA)
Society for Vascular Surgery (USA)
Spanish Society for Family and Community
Medicine (Spain)
Surviving Sepsis Campaign (International)
University of Pennsylvania Health System
Center for Evidence-Based Practice (USA)
UpToDate (USA)
World Health Organization (International)
Box 2. Systems for Grading Evidence and Issuing Guidelines
Based on the Evidence
Atkins and colleagues compared the following six systems [6]:
N The American College of Chest Physicians Evidence-Based Guidelines (http://
www.chestnet.org/education/hsp/guidelinesProducts.php)
N Australian National Health and Medical Research Council Guidelines (http://
www.nhmrc.gov.au/guidelines/index.htm)
N Oxford Centre for Evidence-Based Medicine (http://www.cebm.net/)
N Scottish Intercollegiate Guidelines Network (http://www.sign.ac.uk/)
N US Preventive Services Task Force Recommendations (http://www.ahrq.gov/
CLINIC/uspstfix.htm#Recommendations)
N US Task Force on Community Preventive Services Recommendations (http://
www.thecommunityguide.org/about/findings.html)
Grading Clinical Practice Guidelines
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for appraising evidence proposed by the
Evidence-Based Medicine Working Group
[32], I would conclude that there is little
basis for GRADE.
The GRADE documents suggested that
strong recommendations should require
little debate and would be implemented in
most circumstances [7,29]. At first glance,
this may seem reasonable but there could
be unanticipated consequences, such as
stifling debate about many important
topics, with the result that there is less
thought and less research on that topic.
High-level recommendations using other
grading systems strongly advocated use of
beta-blockade (class I, IIa) [33–34] and
aprotinin (class 1a) [4] in specific surgical
populations. But assuming that the subse-
quent RCTs were appropriately conduct-
ed [5,35], the original high-level recom-
mendations were clearly misguided [4,33–
34]. A major concern about any grading
system is that if enshrined, potentially life-
saving prospective studies might not be
permitted by research ethics boards on the
basis that because a guideline has been
assigned a ‘‘confident’’ grading, equipoise
does not exist.
Popularity and Uptake
The GRADE system has been adopted
as is, or with minor modifications, by a
large number of professional, statutory, and
medically related governance organizations
(Box 1). It is hard to understand why so
many organizations, many of them leading
regulatory or professional groups, would
adopt a system that has no proof of
effectiveness and has demonstrated incon-
sistency [16]. There are several possible
reasons for its popularity: (1) a perceived
need to regulate and reduce ‘‘unnecessary’’
and potentially harmful variation in health
care [36]; (2) GRADE uses attractive
language (such as ‘‘clarity,’’ ‘‘consistency,’’
‘‘helpfulness,’’ and ‘‘rigor’’) [6,37–38]; (3)
the attraction of the promise of clinical
excellence being obtainable through such a
system; (4) influential bodies may adopt
GRADE inorder not tobe leftbehindwhat
some view as a ‘‘state-of-the-art’’ scientific
advance.
GRADE: Potential for Bias
The SSC describes in detail how mem-
bers of the GRADE group interacted with
the sepsisexperts and influenced the grading
decisions [11]. But it is not clear to me why
the GRADE group needed to be involved at
all in the grading decisions given that all the
SSC members are experts. Given also that
the GRADE criteria are conveyed as
‘‘explicit and clear’’ [6], there should be
little need for intensive methodological
consultation from the GRADE group when
experts produce guidelines. While grading
experts might be helpful to explain technical
elements of grading, the above scenario
raises the possibility of the grading process
shaping the medical message.
GRADE: Implications for Practice and
Policy
The GRADE group writes that for
clinicians, strong recommendations should
be seen as a quality criterion or perfor-
mance indicator, and for policy makers, be
adopted as policy [7]. There are similar
efforts underway to synthesize studies and
implement practice guidelines in several
countries, including the UK and the US
[39–41]. But knowing which studies and
guidelines are best (or are valid) [42] is not
straightforward—high-grade recommen-
dations (such as [4,33–34]) have been later
proved wrong [5,35].
It is not clear that the opinion of a
conscientious, judicious, well-educated,
and experienced clinician would necessar-
ily be inferior to a systemized opinion,
such as GRADE, especially if GRADE is
not valid. Conferring a ‘‘strong’’ rating
upon a guideline will constitute a major
deterrent to a clinician considering an
alternative clinical route, particularly if
GRADE recommendations were to be
adopted as a policy by regulatory bodies
[7]. Indeed warnings have been issued
about proposals to convert guidelines into
law [43–44].
What Should Replace GRADE?
A key question that arises when a
system is questioned is: what is the
alternative? There is a very good alterna-
tive to using the GRADE system to rate
Box 3. Antibiotic Use in Sepsis
In 2004 the SSC guidelines recommended that for serious sepsis, intravenous
antibiotic therapy should be rapidly instituted [10]; this guideline was given a
grade ‘‘E.’’ The grading system that was in use in 2004 was adopted from Sackett’s
1989 description [3]: in both cases an ‘‘E’’ grade corresponded to a
recommendation that was supported by so-called level IV or V evidence
(nonrandomized, historical controls, uncontrolled studies, expert opinion)—the
lowest levels possible [10].
In 2008, the SSC issued almost the identical recommendation but this time
assigned to it a grade of 1B (if shock is present) and 1D (if shock is absent), where
grade 1 corresponds to a ‘‘strong’’ [7] recommendation [11]. Three studies
published between 2004 and 2008 (none of them randomized controlled trials)
supported the idea that early antibiotics reduced mortality in sepsis [45–47],
exactly the same conclusions reached by at least six others published before 2004
[48–53]. Although all the studies indicated that antibiotic delay has an adverse
effect, they told the clinician nothing that was new: once the need for an
antibiotic is confirmed, the sooner it is administered the better. Thus it is unclear
why the grading went from grade E in 2004 to grade 1B or 1D in 2004. Was the
different grading simply due to the use of a different grading system in these two
different years? It seems improbable that two systems describing the validity of a
recommendation could arrive at such discordant conclusions. While it is easy to
see how the recommendation received a meritorious commendation in 2008 [11],
it is difficult to see how it did not in 2004 [10].
Box 4. Ventilation in Acute Respiratory Distress Syndrome
In 2004 the SSC guidelines recommended that levels of positive end-expiratory
pressure (PEEP) should be set to prevent lung collapse at expiration [10].
Although most clinicians use PEEP, almost none would be able to quantify lung
collapse at the end of expiration, given that atelectasis is seldom quantified.
Nonetheless, the grade in 2004 was ‘‘E’’ (i.e., very poor) [10]. In 2008, a virtually
identical recommendation received a grade of ‘‘1’’ (i.e., strong) [11]. The results of
three randomized controlled trials examining the effect of PEEP in acute
respiratory distress syndrome (ARDS) [54–56] were made available before the
2008 SSC conference [11]. But none of the trials analyzed PEEP and collapse in
end-expiration; rather they addressed higher versus lower levels of PEEP, and
broadly showed that as tested, PEEP made little or no difference to outcome [54–
56]. Thus, there is no rationale as to how either grading was arrived at, and no
basis for the difference in grading from 2004 to 2008.
Grading Clinical Practice Guidelines
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zations should use published guidelines
while considering the clinical context, the
credentials, and any conflicts of interest
among the authors, as well as the exper-
tise, experience, and education of the
practitioner. If in the future a guideline
grading system is shown to improve
outcome and is without harm, it could
usefully be incorporated into clinical
practice.
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